Skip to main content
3 min read
◆ Mixed look for SlotkinHealthcare

Opinion: Making healthcare more expensive -- bipartisanship s...

She is identified as one of the bipartisan Senate leaders behind a bill requiring insurance coverage for genetic testing.

Opinion: Making healthcare more expensive -- bipartisanship s...
Image · The Wilson Times

SOURCE CHECK

TAP FOR WHY
Outlet credibilityThe Wilson TimesNOT RATED
This article1 analysis · Oct 3, 2026
tl;dr

A libertarian opinion column argues that the Ovarian Cancer IMPACT Act’s insurance-coverage mandate would spread genetic-testing costs across policyholders. The article identifies Sens. Elissa Slotkin and Katie Britt as leaders of the bill.

Community verdict

2 VOTES
How does this story look for
Elissa Slotkin D · MI · SEN
● OPEN

People in this story

SWIPE →
Elissa Slotkin
D · MI · SEN

Senator leading the bill

PRIMARY SUBJECT
Katie Boyd Britt
R · AL · SEN

Senator leading the bill

Britt's version of this story ↗

Part of a bigger story

3 OUTLETS
Slotkin and Britt Introduce Ovarian Cancer Care Legislation

Slotkin and Britt are backing a bipartisan Senate bill to improve ovarian cancer prevention, testing and care. Center outlets present the bill as an effort to expand prevention, testing and care; an opinion column instead argues its insurance mandate would spread genetic-testing costs across policyholders.

Discussion · 0

What's your take?

Loading comments…